| Primary Diagnosis | Year | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | |
| Total | 778 | 874 | 1,029 | 1,254 | 1,421 | 1,482 | 1,654 | 2,059 | 1,791 | 1,212 |
| Emphysema/COPD | 223 | 229 | 287 | 352 | 363 | 380 | 385 | 501 | 428 | 272 |
| Cystic Fibrosis | 98 | 110 | 126 | 160 | 190 | 184 | 197 | 296 | 263 | 185 |
| Idiopathic Pulmonary Fibrosis | 85 | 106 | 121 | 154 | 201 | 198 | 259 | 338 | 289 | 205 |
| Alpha-1-Antitrypsin Deficiency | 46 | 48 | 52 | 70 | 69 | 85 | 101 | 105 | 91 | 62 |
| Primary Pulmonary Hypertension | 137 | 164 | 190 | 215 | 261 | 263 | 301 | 321 | 274 | 164 |
| Retransplant/Graft Failure | 25 | 26 | 35 | 39 | 34 | 39 | 30 | 38 | 35 | 27 |
| Congenital Disease | 43 | 45 | 41 | 41 | 48 | 55 | 60 | 58 | 50 | 30 |
| Other | 85 | 107 | 140 | 186 | 212 | 230 | 259 | 310 | 267 | 205 |
| Unknown | 36 | 39 | 37 | 37 | 43 | 48 | 62 | 92 | 94 | 62 |
| Total (%) | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Emphysema/COPD | 28.7% | 26.2% | 27.9% | 28.1% | 25.5% | 25.6% | 23.3% | 24.3% | 23.9% | 22.4% |
| Cystic Fibrosis | 12.6% | 12.6% | 12.2% | 12.8% | 13.4% | 12.4% | 11.9% | 14.4% | 14.7% | 15.3% |
| Idiopathic Pulmonary Fibrosis | 10.9% | 12.1% | 11.8% | 12.3% | 14.1% | 13.4% | 15.7% | 16.4% | 16.1% | 16.9% |
| Alpha-1-Antitrypsin Deficiency | 5.9% | 5.5% | 5.1% | 5.6% | 4.9% | 5.7% | 6.1% | 5.1% | 5.1% | 5.1% |
| Primary Pulmonary Hypertension | 17.6% | 18.8% | 18.5% | 17.1% | 18.4% | 17.7% | 18.2% | 15.6% | 15.3% | 13.5% |
| Retransplant/Graft Failure | 3.2% | 3.0% | 3.4% | 3.1% | 2.4% | 2.6% | 1.8% | 1.8% | 2.0% | 2.2% |
| Congenital Disease | 5.5% | 5.1% | 4.0% | 3.3% | 3.4% | 3.7% | 3.6% | 2.8% | 2.8% | 2.5% |
| Other | 10.9% | 12.2% | 13.6% | 14.8% | 14.9% | 15.5% | 15.7% | 15.1% | 14.9% | 16.9% |
| Unknown | 4.6% | 4.5% | 3.6% | 3.0% | 3.0% | 3.2% | 3.7% | 4.5% | 5.2% | 5.1% |